⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4541324 | 0.96 | — | — | |
| SCHEMBL10184316 | 0.84 | — | — | |
| SCHEMBL6665645 | 0.84 | — | — | |
| SCHEMBL11917535 | 0.75 | — | — | |
| SCHEMBL1190367 | 0.73 | — | — | |
| SCHEMBL1190324 | 0.73 | — | — | |
| SCHEMBL1190366 | 0.73 | — | — | |
| SCHEMBL1190325 | 0.73 | — | — | |
| SCHEMBL14900784 | 0.73 | ALPL (0.36) | — | |
| SCHEMBL18437540 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137650-A1 | MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) | 11949098 CANADA INC (CA) | 2026-05-21 | — | — | US | claimed |
| EP-4709383-A1 | INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 Canada Inc. (CA) | 2026-03-18 | — | — | EP | claimed |
| WO-2025097247-A1 | METHOD OF TREATMENT OF FIBROSIS WITH INVERSE AGONIST OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 CANADA INC. (CA) | 2025-05-15 | — | — | WO | claimed |
| WO-2024229569-A9 | INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 CANADA INC. (CA) | 2025-01-30 | — | — | WO | claimed |
| WO-2024229569-A1 | INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 CANADA INC. (CA) | 2024-11-14 | — | — | WO | claimed |
| US-20220000864-A1 | MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs) | 11949098 CANADA INC. (CA) | 2022-01-06 | — | — | US | claimed |
| EP-3883929-A1 | 4,5,6,7-TETRAHYDRO-L-BENZOTHIOPHENE MODULATORS OF RETINOIC ACID RECEPTOR RELATED (RAR) ORPHAN NUCLEAR RECEPTORS (RORS) | 11949098 Canada Inc. (CA) | 2021-09-29 | — | — | EP | claimed |
| CN-113166130-A | 4,5,6, 7-tetrahydro-L-benzothiophene modulators of retinoic acid receptor-associated (RAR) orphan nuclear receptors (ROR) | 11949098加拿大股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-102574685-B | Methods and reagents for inhibiting or reducing scale formation during phosphoric acid production | CYTEC TECHNOLOGY CORP. (US) | 2016-02-17 | — | — | CN | claimed |
| EP-2900276-A1 | BIFUNCTIONAL CHELATING AGENTS | General Electric Company (US) | 2015-08-05 | — | — | EP | claimed |
| WO-2010009166-A1 | OXINDOLYL INHIBITOR COMPOUNDS | GILEAD COLORADO, INC. (US) | 2010-01-21 | — | — | WO | claimed |
| US-20100009990-A1 | IMIDAZOLYL PYRIMIDINE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. | 2010-01-14 | — | — | US | claimed |
| EP-1442489-B1 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ELECTROCHEMICAL CELLS | YARDNEY TECH PROD (US) | 2009-09-16 | — | — | EP | claimed |
| US-20090005374-A1 | IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS | GILEAD SCIENCES, INC. | 2009-01-01 | — | — | US | claimed |
| WO-2009002534-A1 | IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS | GILEAD COLORADO, INC. (US) | 2008-12-31 | — | — | WO | claimed |
| US-6846827-B1 | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2005-01-25 | — | — | US | claimed |
| EP-1226126-B1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-01-05 | — | — | EP | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |